Copyright
©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 319-337
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.319
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.319
Drug | Prevention | Hepatic injury | Treatment |
5-Amino salicilyc acid | Check before start treatment annual check | Drug induced hepatitis; Drug induced cholestasic; Granuloma formation (sulfa) | Stop drug; Follow-up |
Tiopurines (azathioprine/6MP) | Check before treatment: TPMT and liver test; Check every week in first month, withing 2 wk in 2nd mo, every 3 mo | Drug induced hepatitis; Drug induced cholestasic; Sinusoidal obstruction syndrome; Nodular regenerative hyperplasia; Peliosis hepatitis | Drug induced hepatitis and cholestasic are idyosincratic reactions; More cases in the first three months of treatment; Stop drug |
Methotrexate | Check before start treatment; Check every 2 wk until 2nd mo; Check every 3 mo; Add folic acid | Fibrosis/cirrhosis; Steatohepatitis | Stop MTX if ALT > 3 times; Despite alcohol; Comsume; Fibroscan |
- Citation: Núñez F P, Castro F, Mezzano G, Quera R, Diaz D, Castro L. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World J Hepatol 2022; 14(2): 319-337
- URL: https://www.wjgnet.com/1948-5182/full/v14/i2/319.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i2.319